Windtree Therapeutics Inc expected to post a loss of $8.11 a share - Earnings Preview

Windtree Therapeutics

02/08/2024 13:44

* Windtree Therapeutics Inc  WINT.OQ   WINT.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 5 (estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Windtree Therapeutics
Inc is
for a loss of $8.11 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Hold".​
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $7.00​, below​ its last closing price
of $10.01. ​​​

This summary was machine generated August 2 at 12:44 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)